What is it about?

The identity of the enzyme(s) responsible for the S-oxidation of the mucoactive drug S-carboxymethyl- L-cysteine (SCMC) is unknown but the protein(s) are a susceptibility factor for a number of chronic degenerative diseases. The structural similarities between the amino acid L-cysteine and SCMC have raised the possibility that cysteine dioxygenase (CDO) may be responsible for this biotransformation reaction. Both CDO and SCMC S-oxygenase were found to require Fe2+ for enzymatic activity, and both enzyme activities were inhibited by Fe2+ and Fe3+ chelators. However, sulphydryl group modification of the enzymes resulted in the activation of the S-oxidation of SCMC but inhibition of the S-oxidation of L-cysteine. When the two enzyme activities were quantified in 20 female hepatic cytosolic fractions no linear correlation in the production of their respective metabolites was seen. The results of this investigation indicate that CDO is not responsible for the S-oxidation of SCMC in the rat.

Featured Image

Why is it important?

The first reported experimental working attempting to link cysteine dioxygenase to the S-oxidation of S-carboxymethyl-L-cysteine.

Read the Original

This page is a summary of: Lack of congruence between cysteine dioxygenase activity andS-carboxymethyl-l-cysteineS-oxidation activity in rat cytosol, Journal of Pharmacy and Pharmacology, August 2004, Wiley,
DOI: 10.1211/0022357043897.
You can read the full text:



Be the first to contribute to this page